Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$907M |
| 2 |
Apple
AAPL
|
+$260M |
| 3 |
Microsoft
MSFT
|
+$223M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$471M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$177M |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$160M |
| 4 |
Petrobras
PBR
|
+$153M |
| 5 |
Adobe
ADBE
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.79% |
| 2 | Healthcare | 12.41% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Talos Energy
TALO
$2.42B
| $249K | ﹤0.01% |
16,068
| – | – |
|
752
iShares Silver Trust
SLV
$30.2B
| $248K | ﹤0.01% |
13,299
+1,698
| +15% | +$35.4K |
|
|
FBRT
753
Franklin BSP Realty Trust
FBRT
$633M
| $246K | ﹤0.01% |
+18,268
| New | +$260K |
|
754
Public Storage
PSA
$60.7B
| $246K | ﹤0.01% |
787
-50
| -6% | -$17.3K |
|
|
HDV
755
iShares Core High Dividend ETF
HDV
$14.8B
| $245K | ﹤0.01% |
+12,215
| New | +$258K |
|
756
O'Reilly Automotive
ORLY
$76.7B
| $245K | ﹤0.01% |
5,820
+1,320
| +29% | +$56.8K |
|
757
Pacific Biosciences
PACB
$457M
| $243K | ﹤0.01% |
54,882
| – | – |
|
758
HSBC
HSBC
$352B
| $242K | ﹤0.01% |
7,413
-557
| -7% | -$18.1K |
|
759
Vanguard Russell 2000 ETF
VTWO
$18B
| $241K | ﹤0.01% |
3,519
+501
| +17% | +$37.3K |
|
760
FedEx
FDX
$73.6B
| $240K | ﹤0.01% |
+1,057
| New | +$226K |
|
761
Southwest Airlines
LUV
$24.1B
| $239K | ﹤0.01% |
6,629
-716
| -10% | -$30.8K |
|
762
Phillips Edison & Co
PECO
$5.31B
| $239K | ﹤0.01% |
7,161
-34,281
| -83% | -$1.16M |
|
763
iShares Biotechnology ETF
IBB
$9.55B
| $236K | ﹤0.01% |
2,007
-979
| -33% | -$116K |
|
764
Vanguard Dividend Appreciation ETF
VIG
$114B
| $235K | ﹤0.01% |
+1,641
| New | +$250K |
|
765
Colgate-Palmolive
CL
$73.2B
| $234K | ﹤0.01% |
2,918
+119
| +4% | +$9.3K |
|
766
Constellation Energy
CEG
$95.3B
| $230K | ﹤0.01% |
4,023
+370
| +10% | +$22.3K |
|
767
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.42B
| $223K | ﹤0.01% |
+5,155
| New | +$233K |
|
768
iShares S&P 500 Growth ETF
IVW
$78.1B
| $223K | ﹤0.01% |
+3,695
| New | +$245K |
|
769
Philips
PHG
$25.9B
| $223K | ﹤0.01% |
+12,119
| New | +$261K |
|
770
Canadian National Railway
CNI
$76.6B
| $222K | ﹤0.01% |
1,977
-16
| -0.8% | -$1.87K |
|
771
Humana
HUM
$43.5B
| $218K | ﹤0.01% |
+466
| New | +$207K |
|
|
PCSB
772
DELISTED
PCSB Financial Corporation
PCSB
| $218K | ﹤0.01% |
+11,401
| New | +$215K |
|
773
iShares MSCI Sweden ETF
EWD
$596M
| $207K | ﹤0.01% |
6,786
-4,380
| -39% | -$155K |
|
774
Copart
CPRT
$26.7B
| $206K | ﹤0.01% |
7,592
+588
| +8% | +$16.7K |
|
775
FS KKR Capital
FSK
$3.12B
| $205K | ﹤0.01% |
10,540
+201
| +2% | +$4.26K |
|
Similar funds
Ken Fisher's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Fisher held 1,196 positions worth $141B, down 17% from $169B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Fisher's Q2 2022 filing shows 110 new, 483 increased, 318 reduced and 131 closed positions. Its largest new stake was Woodside Energy: 6,156,348 shares worth $133M. The largest sale was Eli Lilly, an estimated $471M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- Ken Fisher's largest Q2 2022 buy was Woodside Energy: 6,156,348 shares worth $133M.
- Ken Fisher added most to Johnson & Johnson in Q2 2022, an estimated $907M increase.
- Ken Fisher's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $471M.
- Ken Fisher fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $160M.
- Ken Fisher's ten largest holdings make up 30% of its $141B portfolio in Q2 2022.
- Ken Fisher opened 110 new positions and closed 131 in Q2 2022.
- Ken Fisher's portfolio value fell 17% quarter-over-quarter to $141B.
Based on Fisher Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.